182 related articles for article (PubMed ID: 7953621)
1. Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a kappa-opioid receptor agonist, in the mouse.
Bhargava HN; Thorat SN
Brain Res; 1994 Jun; 649(1-2):111-6. PubMed ID: 7953621
[TBL] [Abstract][Full Text] [Related]
2. Non-competitive antagonism of N-methyl-D-aspartate receptor inhibits tolerance to the analgesic action of U-50,488H, a kappa-opiate receptor agonist in the rat.
Bhargava HN
Gen Pharmacol; 1995 Sep; 26(5):1055-60. PubMed ID: 7557250
[TBL] [Abstract][Full Text] [Related]
3. Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50,488H and brain and spinal cord kappa-opioid receptors in the rat.
Bhargava HN; Matwyshyn GA; Gudehithlu KP
Pharmacology; 1995 Nov; 51(5):323-30. PubMed ID: 8584584
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of LY235959, a competitive antagonist of the NMDA receptor on kappa-opioid receptor agonist induced responses in mice and rats.
Bhargava HN; Thorat SN
Brain Res; 1997 Feb; 747(2):246-51. PubMed ID: 9045999
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of a kappa-opioid receptor agonist-induced analgesia by L-tyrosine and L-tryptophan.
Barjavel MJ; Thorat SN; Bhargava HN
Eur J Pharmacol; 1994 Jun; 258(3):173-8. PubMed ID: 8088353
[TBL] [Abstract][Full Text] [Related]
6. L-type Ca2+ channel modulation by dihydropyridines potentiates kappa-opioid receptor agonist induced acute analgesia and inhibits development of tolerance in rats.
Gullapalli S; Ramarao P
Neuropharmacology; 2002 Mar; 42(4):467-75. PubMed ID: 11955518
[TBL] [Abstract][Full Text] [Related]
7. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
Yamamoto T; Ohno M; Ueki S
Eur J Pharmacol; 1988 Oct; 156(1):173-6. PubMed ID: 2850208
[TBL] [Abstract][Full Text] [Related]
8. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist.
Bhargava HN; Ramarao P; Gulati A
Eur J Pharmacol; 1989 Mar; 162(2):257-64. PubMed ID: 2542058
[TBL] [Abstract][Full Text] [Related]
9. Modification of the binding of [3H]MK-801 to brain regions and spinal cord of rats treated chronically with U-50,488H, a kappa-opioid receptor agonist.
Bhargava HN; Kumar S
Brain Res; 1997 Feb; 749(2):347-50. PubMed ID: 9138737
[TBL] [Abstract][Full Text] [Related]
10. Disability of development of tolerance to morphine and U-50,488H, a selective kappa-opioid receptor agonist, in neuropathic pain model mice.
Sounvoravong S; Takahashi M; Nakashima MN; Nakashima K
J Pharmacol Sci; 2004 Mar; 94(3):305-12. PubMed ID: 15037816
[TBL] [Abstract][Full Text] [Related]
11. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids.
Elliott K; Minami N; Kolesnikov YA; Pasternak GW; Inturrisi CE
Pain; 1994 Jan; 56(1):69-75. PubMed ID: 7512709
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide synthase inhibition blocks tolerance to the analgesic action of kappa-opiate receptor agonist in the rat.
Bhargava HN
Pharmacology; 1994 Apr; 48(4):234-41. PubMed ID: 7513892
[TBL] [Abstract][Full Text] [Related]
13. Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance.
Lutfy K; Doan P; Nguyen M; Weber E
Eur J Pharmacol; 1999 Nov; 384(1):1-5. PubMed ID: 10611412
[TBL] [Abstract][Full Text] [Related]
14. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
Ho BY; Takemori AE
J Pharmacol Exp Ther; 1989 Aug; 250(2):508-14. PubMed ID: 2547935
[TBL] [Abstract][Full Text] [Related]
15. Effect of thyrotropin releasing hormone on U-50,488H-induced pharmacological responses in mice.
Bhargava HN; Thorat SN
Brain Res; 1993 Oct; 625(1):120-4. PubMed ID: 8242390
[TBL] [Abstract][Full Text] [Related]
16. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats.
Hiramatsu M; Murasawa H; Nabeshima T; Kameyama T
J Pharmacol Exp Ther; 1998 Mar; 284(3):858-67. PubMed ID: 9495843
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and behavioral studies on the interaction between mu- and kappa-opiate agonists in mice.
Thorat SN; Veeranna ; Reddy PL; Bhargava HN
Brain Res; 1993 Jul; 615(2):191-8. PubMed ID: 8395957
[TBL] [Abstract][Full Text] [Related]
18. Modulation of kappa-opioid receptor mediated tolerance in the guinea-pig ileum by chronic co-administration of dihydropyridines.
Garaulet JV; Laorden ML; Milanés MV
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jun; 354(1):72-9. PubMed ID: 8832591
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
Bhargava HN; Gulati A; Ramarao P
J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075
[TBL] [Abstract][Full Text] [Related]
20. The effect of U-50,488H, a kappa-opiate receptor agonist on tolerance to the analgesic and hyperthermic effects of morphine in the rat.
Bhargava HN; Matwyshyn G; Ramarao P
Gen Pharmacol; 1991; 22(3):429-34. PubMed ID: 1651266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
